Clinical Trials Logo

Clinical Trial Summary

The present randomized controlled study aims to investigate the effectiveness of a combined regimen of letrozole and gonadotropin with dose adjustments based on body mass index (BMI) compared to a conventional only gonadotropin regimen in intrauterine insemination (IUI) cycles for couples experiencing unexplained infertility. The study was conducted at a tertiary university hospital's Assisted Reproductive Technologies (ART) center from January 2023 to January 2024. Couples with unexplained infertility were enrolled based on comprehensive assessments, and randomization was performed based on national ID (odd or even). The Conventional Only Gonadotropin (COG) group received recombinant FSH based on body mass index (BMI), while the Combined Letrozole-Gonadotropin (CLG) group received letrozole followed by gonadotropin with dose adjustments based on BMI. Ovulation induction and IUI were performed according to standard protocols. Clinical outcomes, gonadotropin consumption, and pregnancy rates were compared between groups. Among 317 IUI cycles, 131 couples with unexplained infertility were randomized (CLG: 61, COG: 70). Demographic parameters were similar between groups. The CLG group had lower daily gonadotropin doses (67 ± 18 IU/D vs. 76 ± 11 IU/d, p=0.01) and total gonadotropin consumption (750 IU vs. 825 IU, p=0.01) with comparable ovulation and clinical pregnancy rates. The COG group exhibited higher multiple pregnancy rates, although not statistically significant (CLG vs. COG; 1/61 vs. 3/70, p=0.4). The study suggests that the combined letrozole and gonadotropin regimen with BMI-based dose adjustments in IUI cycles for unexplained infertility is associated with reduced gonadotropin consumption and potentially lower multiple pregnancy rates.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06413771
Study type Interventional
Source Uludag University
Contact
Status Completed
Phase N/A
Start date January 1, 2023
Completion date February 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05506722 - Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity N/A
Active, not recruiting NCT05896657 - Modulation of Reproductive Microbiota by Ligilactobacillus Salivarius CECT5713 N/A
Completed NCT06290518 - Modulation of Reproductive Microbiota by Ligilactobacillus Salivarius CECT5713 N/A
Completed NCT03319654 - Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle N/A
Completed NCT04446572 - Application of Lactobacillus Salivarius CECT5713 in Infertility of Unknown Origin Phase 2
Completed NCT04141436 - Hypnofertility for Women Undergoing In Vitro Fertilization (HWUIVF) N/A
Completed NCT05680350 - Relation Between MicroRNA 203 and 210 and Sparing the Laparoscopic Examination in Cases of Unexplained Infertility N/A
Recruiting NCT04144244 - Comparison of the Effect of Microchip and Density Gradient Methods in Intrauterine Insemination Cycles N/A
Recruiting NCT05599724 - PMA-FERTITHEQUE Biocollection
Completed NCT05190250 - Pro-inflammatory Cytokines and Implantation Process in Women With Primary Idiopathic Infertility
Recruiting NCT05824819 - Endometriosis and Peritoneal Dysbiosis N/A
Recruiting NCT06174298 - The Role of Granulocyte Colony Stimulating Factor in Embryo Transfer Outcomes Phase 4
Completed NCT03085433 - Sperm Selection by Microfluidic Separation Improves Embryo Quality N/A
Recruiting NCT06342856 - Evaluation of Treatment With Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile Men With Idiopathic Oligoasthenoteratospermia Early Phase 1
Terminated NCT05390606 - Effects of Flourish HEC and BioGenesis to Improve Conception Phase 1
Completed NCT03178695 - Inovium Ovarian Rejuvenation Trials Phase 1
Not yet recruiting NCT04945265 - Effects of Age and Infertility on Ovarian Granulosa Cell Function
Active, not recruiting NCT03799107 - Developmental Epidemiological Study of Children Born Through Reproductive Technology
Completed NCT05789407 - Organic Pollutants in Pelvic Endometriosis N/A
Completed NCT03361618 - Effect of Oral Zinc Sulfate Supplementation on Enzymes of Urate Pathway N/A